您当前位置：首页 > 国际期刊-Signal Transduction and Targeted Therapy期刊投稿发表详细信息

Signal Transduction and Targeted Therapy Q1

期刊收录：
SCIE
Scopus
DOAJ

基本信息

期刊ISSN：
2095-9907
期刊简拼：
SIGNAL TRANSDUCT TAR
年发文章数：
272
E-ISSN：
2059-3635
Gold OA文章占比
99.57%
研究文章占比：
60.29%
是否OA：
Yes
Jcr分区：
Q1
中科院分区：
1区

出版信息

出版商：
Springer Nature
涉及研究方向：
Biochemistry, Genetics and Molecular Biology-Genetics
出版国家：
United Kingdom
出版语言：
English
出版周期：
出版年份：
2016

2023-2024最新影响因子:40.8
自引率:1.20%
五年影响因子:40.5
JCI期刊引文指标:4.42
h-index:暂无h-index数据
CiteScore:44.50

期刊关键词

1区 SCIE Scopus DOAJ 医学 BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CELL BIOLOGY 细胞生物学

期刊简介

Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, including but not limited to: cancer, cardiovascular diseases, autoimmune diseases, and nervous system diseases.

《Signal Transduction and Targeted Therapy》期刊已被查看：次
期刊简写：SIGNAL TRANSDUCT TAR

此期刊被最新的JCR期刊SCIE收录